Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -33,359 | -19,275 | -9,509 | -25,404 | -15,013 |
| Depreciation Amortization | 1,076 | 582 | 177 | 162 | 83 |
| Accounts receivable | 0 | 0 | N/A | 8 | N/A |
| Accounts payable and accrued liabilities | 283 | 534 | 1,771 | -6 | 127 |
| Other Working Capital | -1,013 | 369 | 817 | 10,046 | 8,914 |
| Other Operating Activity | 6,801 | 798 | -998 | 9,546 | 5,296 |
| Operating Cash Flow | $-26,212 | $-16,992 | $-7,742 | $-5,648 | $-593 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -68,827 | -79,469 | -88,370 | N/A | N/A |
| PPE Investments | -2,804 | -1,485 | -411 | -943 | -579 |
| Investing Cash Flow | $-71,631 | $-80,954 | $-88,781 | $-943 | $-579 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 2,000 |
| Common Stock Issued | 139,135 | 139,085 | 138,975 | 117,077 | 117,582 |
| Other Financing Activity | 0 | 0 | 0 | 48,365 | 46,365 |
| Financing Cash Flow | $139,135 | $139,085 | $138,975 | $165,442 | $165,947 |
| Exchange Rate Effect | -20 | -6 | -7 | -11 | -10 |
| Beginning Cash Position | 159,404 | 159,404 | 159,404 | 564 | 564 |
| End Cash Position | 200,676 | 200,537 | 201,849 | 159,404 | 165,329 |
| Net Cash Flow | $41,272 | $41,133 | $42,445 | $158,840 | $164,765 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,212 | -16,992 | -7,742 | -5,648 | -593 |
| Capital Expenditure | -2,804 | -1,485 | -411 | -943 | -579 |
| Free Cash Flow | -29,016 | -18,477 | -8,153 | -6,591 | -1,172 |